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A B S T R A C T
Human granulosa cells acquired as leftover from IVF treatment can be used to study infertility problems and are
a valuable tool in the research of follicle maturation and ovulation. There is a need for more defined and long-
term culture protocols for studying the response of granulosa cells upon treatment with selected hormones/
chemicals. In the current study, we tested the effect of adding FGF2, IGF2 and FSH into defined basal medium in
order to find culture conditions that would support proliferation of cumulus and mural granulosa cells along
with the expression of common granulosa cell type markers such as FSHR, AMHR2, LHR and CYP19A1. We found
that FGF2, IGF2 together with FSH helped to retain granulosa cell marker expression while supporting cell
survival at least for two weeks of culture. The defined serum-free culture conditions for long-term culturing will
be valuable in providing new standards in the research of human granulosa cells.
1. Introduction
1.1. The function of granulosa cells in folliculogenesis
Follicle maturation and ovulation are complex biological processes
that primarily determine the fertility of women. During maturation, the
oocyte heavily depends on external support from granulosa cells (GCs)
and theca cells (TCs), which provide the oocyte with metabolites and
regulatory molecules (Edson et al., 2009). Granulosa cells are divided
into two types: cumulus GCs (CGCs) that surround the oocyte, and
mural GCs (MGCs) that are positioned peripherally in the follicle.
During the follicular cycle TCs synthesize androstenedione as a re-
sponse to luteinizing hormone (LH) released from the pituitary gland,
while GCs express aromatase (CYP19A1) as a response to follicle sti-
mulating hormone (FSH). CYP19A1 converts androstenedione into es-
tradiol, which is necessary to achieve ovulation (Hillier, 1994; Lasley
et al., 1975; Ryan and Petro, 1966; Sasano et al., 1989). Therefore,
disturbances in GC function can lead to reduced fertility or even in-
fertility.
1.2. Molecular markers of GCs
Several different markers can be used to characterise GC phenotype
and differentiation status. The FSH receptor (FSHR), anti-Müllerian
hormone (AMH) and aromatase are often used to characterise these
cells. GCs start expressing FSHR during the primary follicular phase
(Oktay et al., 1997) and still express it during preantral and Graafian
stages (Yamoto et al., 1992), while AMH and its receptor (AMHR2) are
expressed during primary, secondary and small antral phases of the
follicle (Xu et al., 2016) and expression decreases notably at later stages
(Cheon et al., 2018; Weenen et al., 2004). The LH receptor (LHR) ex-
pression is detectable in early antral follicles and later stages of ma-
turation (Yung et al., 2014). Aromatase is already detectable in small
follicles, but its expression increases as the follicle matures (Sasano
et al., 1989). In conjunction with the traditional markers, one can use
additional targets to characterise GCs differentiation status. Cyto-
chrome P450 side-chain cleavage enzyme (CYP11A1, also known as
P450scc), required for the first stages of steroidogenesis, is usually
considered to be abundant in TCs, but it is also detectable in GCs,
especially in luteinized GCs (Sasano and Sasano, 1989). Gonadotropin-
releasing hormone receptor (GnRHR) is present only in preovulatory
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and luteinized GCs (Choi et al., 2006).
1.3. In vitro cultivation of GCs
Over the years, several GC lines have been developed, that are re-
latively easy to work with (Bayasula et al., 2012; Hosokawa et al., 1998;
Ishiwata et al., 1984; Nishi et al., 2001; Nitta et al., 2001; Rainey et al.,
1994; Tajima et al., 2002; van den Berg-Bakker et al., 1993). However,
these cell lines may differ from primary GCs by hormone synthesis and
responsiveness, aromatase activity and even the number of chromo-
somes (Havelock et al., 2004). Thus, there is a need for a reliable cell
culture protocol that would allow to cultivate primary human GCs
while maintaining GC identity, including responsiveness to relevant
hormones. Several protocols have been published (Sarah C Baumgarten
et al., 2015; Brůcková et al., 2008; Chang et al., 2016; Chatterjee et al.,
2014; Figenschau et al., 1997; Grossman et al., 2008; Karamouti et al.,
2008; Kossowska-Tomaszczuk et al., 2010; Kranc et al., 2017; Ophir
et al., 2014; Prapa et al., 2015; Schipper et al., 1993; Taieb et al., 2011;
Tureck and Strauss, 1982; Wickham et al., 2013). However, most of
them are either short-term cultures (up to 7 days) or use undefined
serum in growth medium. Inclusion of serum can make interpretation
of the results more difficult and may not be consistent over longer
periods of time, since serum batches can differ from each other and that
can influence the results of the experiment.
Several of these protocols use growth factors to promote cell pro-
liferation and steroidogenesis. Insulin-like growth factors (IGFs) are
important players in regulation of ovarian steroidogenesis in humans
(Giudice, 1992). Actions of IGFs can be mediated via insulin receptors
(INSR), type I IGF receptors (IGF1R) and type II IGF receptors (IGF2R)
(Rechler and Nissley, 1986). Growth factors IGF1 and IGF2 mainly
modulate the steroidogenic response via IGFR1 and enhance GC steroid
production in vitro (Willis et al., 1998). It has been found that human
GCs from preovulatory follicles selectively express IGF2, and IGF1 ex-
pression is not detectable (el-Roeiy et al., 1993; Geisthovel et al., 1989).
The expression of IGF2 by human GCs is enhanced by FSH and together
these molecules stimulate CYP19A1 expression in CGCs and regulate
their proliferation and differentiation (Sarah C Baumgarten et al.,
2015). While an early study analysing the proliferative effect of IFG2
has found that human GCs respond positively to the IGF2 treatment (Di
Blasio et al., 1994), a more recent study states that IGF2 alone does not
enhance GC proliferation, but the proliferative effect is detected only
together with FSH (Sarah C Baumgarten et al., 2015).
Fibroblast growth factors (FGFs) are potent regulators of growth
and differentiation in reproductive tissues, where FGF2 (also known as
basic fibroblast growth factor - bFGF) is the most studied and has been
shown to promote GC proliferation while decreasing steroidogenesis of
these cells (Gospodarowicz and Bialecki, 1979; McAllister, 1995; Price,
2016). The expression of FGF2 and its receptors in human GCs has been
demonstrated (Di Blasio et al., 1993; Watson et al., 1992). Out of the
main types of FGF receptors, FGFR2 and FGFR3 are present in GCs of
primordial, primary and secondary follicles and FGFR3 can be detected
also in antral follicles, whereas FGFR4 is missing from primordial fol-
licles, but is present in primary and secondary follicles (Ben-Haroush
et al., 2005). The expression of FGF2 protein has been found in GCs
from primary and secondary follicles and similarly to the expression
FGF receptors, it is only detectable in adult women (Ben-Haroush et al.,
2005). Interestingly, transcripts of FGF2 together with all the four
receptors were detected by qPCR from primary to antral follicles (Ben-
Haroush et al., 2005). The latter is in concordance with a more recent
study where the analysis of transcriptional profiles of antral granulosa
cells showed evidence about the presence of all the four main FGF re-
ceptor types (Kõks et al., 2009). It has also been noted that the mRNA
expression of FGF2 decreases during early follicle development from
non-growing to small secondary follicles (Quennell et al., 2004).
1.4. The aim of the study
The aim of this study was to develop a serum-free primary human
GC cultivation protocol that would support proliferation of the FSH
responsive (expressing FSHR) cells for in vitro cellular experiments,
providing a reliable tool to study the biology of human GCs.
2. Materials and methods
2.1. Granulosa cells retrieval and purification
The study was approved by the Research Ethics Committee of the
University of Tartu (289/M-8). GCs were derived in the Women's Clinic
of Tartu University Hospital during intracytoplasmic sperm injection
(ICSI) procedure from women undergoing in vitro fertilization (IVF)
treatment. The samples were collected anonymously and thus no pa-
tient information was made available for the researchers. Ovarian
hormonal stimulation was conducted according to the GnRH antagonist
(Cetrotide, Merck Serono, Geneva, Switzerland) protocol with the ad-
ministration of recombinant FSH (Gonal-F, Merck Serono, Darmstadt,
Germany) to all patients. All patients underwent ovum pick-up (OPU)
after 36h of human chorionic gonadotropin (hCG) administration
(Ovitrelle, Merck Serono, Germany) with the puncture of follicles
≥15 mm in size. Cumulus and mural GCs were collected separately.
CGCs were collected 4h after OPU during oocyte denudation for
ICSI, lasting up to 5 min with type IV-hyaluronidase extracted from
bovine testes (Sigma-Aldrich, Saint Louis, MO, USA) and diluted in
Sperm preparation Medium (MediCult, Jyllinge, Denmark). The cells
were pooled together and centrifuged at 450g for 10 min, and the su-
pernatant was removed. The cells were separated on a 50% density
gradient of PureSperm 100 (Nidacon, Mölndal, Sweden) in Universal
IVF Medium (MediCult), and washed three times in Universal IVF
Medium at 37 °C.
For MGCs, the follicular fluid of all patients was pooled, centrifuged
at 450g for 10 min, and the supernatant was removed. The cells were
separated on a 50% density gradient of PureSperm 100 (Nidacon) in
Universal IVF Medium (MediCult), and washed three times in Universal
IVF Medium at 37 °C.
2.2. Cell culture
The cells were frozen, thawed, pooled together (pools of 10–30
patients, depending on the size of the experiment). Live cells were
counted manually with hemocytometer and trypan blue staining.
500 000 live cells were plated onto Matrigel-covered (Corning, New
York, NY, USA) 6-well plates in DMEM/F12 growth medium (Lonza AG,
Basel, Switzerland) with 20% KnockOut Serum Replacement (KSR)
(Thermo Scientific, Waltham, MA, USA), 1% penicillin/streptomycin
(Naxo, Tartu, Estonia) and Primocin (100 μg/ml) (InvivoGen, San
Diego, CA, USA). IGF2 (50 ng/ml) (Bio-Techne, Minneapolis, MN,
USA), FGF2 (8 ng/ml) (Enantis, Brno-Bohunice, Czech Republic), both,
or none were added to the growth medium. The effect of FSH (1 U/ml)
(Gonal-F, Merck Serono) was tested in the IGF2 and FGF2-containing
medium starting from day 4, because it has been shown that GCs are not
responsive to hormones right after collection (Ophir et al., 2014).
Growth medium was changed daily. Cells were passaged using TrypLE
(Thermo Scientific), half of the cells were replated and half were lysed
using QIAzol lysis reagent (Qiagen, Hilden, Germany). Cell
Abbreviations
GCs granulosa cells
CGCs cumulus granulosa cells
MGCs mural granulosa cells
TCs theca cells
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proliferation was analysed on the days of passaging by counting the live
cells in a hemocytometer. Cell morphology was analysed by visual
observation. All cell culture experiments were repeated three times. In
preliminary experiments the effect of freezing and thawing cells, as well
as the effect of passaging was studied and no significant effects on the
expression levels of the selected target genes were observed.
2.3. RNA purification, cDNA synthesis and qPCR
For RNA purification miRNeasy Micro Kit (Qiagen) was used ac-
cording to manufacturer's guidelines. All RNA samples were treated
with DNase from RNase-Free DNase Set (Qiagen). For cDNA synthesis
RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific) was
used. Based on literature FSHR, AMHR2, LHR, CYP19A1, GnRHR, AMH
and CYP11A1 were selected as GC markers to be analysed in the current
study. Additionally, IGF1, IGF2, IGF1R, IGF2R, INSR, FGF2, FGFR1,
FGFR2, FGFR3, and FGFR4 were selected for qPCR analysis. Primers
were designed using Primer-BLAST online software (Ye et al., 2012). All
used primer sequences are available in supplementary table ST1. qPCR
was performed using Maxima SYBR Green/ROX qPCR Master Mix (2X)
(Thermo Scientific) in Roche LightCycler 480 and the results were
analysed using the manufacturer's software.
2.4. Statistical analyses
During subsequent analyses the expression levels of all targets were
normalized to succinate dehydrogenase complex flavoprotein subunit A
(SDHA) and were shown relative to the starting point of frozen and
thawed cells using the ΔΔCt method. Statistical analyses were done
using R Project software (version 3.5.2). For pairwise comparisons
Student's t-test was used and the differences between groups were
considered statistically significant when p < 0.05 after Bonferroni
correction for multiple testing.
3. Results
3.1. Granulosa cell marker genes FSHR, AMHR2, LHR, CYP19A1, GnRHR
and AMH have similar expression level in cumulus and mural cell types after
cell retrieval
First, we characterized and compared the expression of our selected
genes of interest in freshly thawed CGCs and MGCs. In addition to
common GC-associated genes, we analysed the expression levels of
IGF1/2, FGF2 and their main receptors in these cells. Growth factors
IGF1/2 and FGF2 have been used before to support granulosa cell
growth (Di Blasio et al., 1994), but comprehensive analysis of GC
marker gene expression in long-term cell culture has not been studied
under serum-free conditions. We did not detect any significant differ-
ences in the expression of most of the selected granulosa marker genes
such as FSHR, AMHR2, LHR, CYP19A1, GnRHR and AMH between these
two GC types (Fig. 1). However subtle differences in the expression of
CYP11A1, IGF2 and IGF1R between CGCs and MGCs were statistically
different, while the difference in the expression of IGF1 was not due to
larger differences between biological replicates. The expression of
FGFR2 in both cell types together with FGFR3 in MGCs was barely
detectable and the expression of IGF1 and FGFR3 in CGCs was detected
at very low level compared with the other targets.
3.2. Combining FGF2 with IGF2 in GC growth medium supports CGC cell
proliferation while retaining the expression of FSHR longer during 24 days in
culture
Here our goal was to find serum-free culture conditions for primary
GCs which could support cell growth and maintain the expression of
main GC marker genes. We selected a more defined serum alternative,
KnockOut™ Serum Replacement and a DMEM/F12 basal medium
together with the usage of Matrigel coated cultureware to grow GCs.
Based on literature we added FGF2 to support GC proliferation and
IGF2 as a crucial regulator of GC proliferation and differentiation. To
study the effect of growth factors IGF2 and FGF2 on the expression
levels of our selected target genes, we cultivated CGC cells for 24 days
in four different growth media: regular (no growth factors added), with
IGF2, with FGF2, and with IGF2+FGF2. Time points were taken on
days 0, 4, 13 and 24.
The CGCs that were cultivated without growth factors or with IGF2
only, had similarly low survival rate (Fig. 2b). Out of 500 000 cells
plated, only around 150 000 survived until day 24. The CGCs cultivated
in FGF2 medium had the highest proliferation speed, as cell count in-
creased 2.58 times in 24 days. Cells in IGF2+FGF2 medium multiplied
too, but not as fast as in the FGF2 medium. By day 24 the cell count had
increased 1.74 times, suggesting that FGF2 increases and IGF2 de-
creases cell proliferation speed.
The morphology of CGCs slowly changed over time from small and
round to long and narrow, more similar to fibroblasts. The culture
mediums supporting the cell proliferation seemed to be more prone to
induce this phenotype. Photos of CGCs in different growth media are
shown in supplementary figure SF1.
The results of qPCR (supplementary table ST2) showed that from GC
markers only FSHR expression increased by day 4 in all media but
quickly decreased after that (Fig. 2a). The expression of other markers
that were tested in this experiment – AMHR2, LHR, CYP19A1 and
GnRHR – either started decreasing immediately or stayed around the
same level by day 4 and decreased after that. The expression levels of
IGF2 and all IGF receptors all decreased rapidly after the start of the
experiment and stayed low until the end of the experiment at day 24.
The expression of IGF1 started out below the detection level and in-
creased slightly above it by the end of the experiment. The expression of
FGF2 and its main receptor FGFR1 decreased by day 4 but started ra-
pidly increasing after that. The other FGF receptors had low expression
levels for the whole duration of the experiment.
As our aim was to select culture conditions that support cell pro-
liferation together with FSHR expression, we found FGF2 and IGF2
synergistically support this phenotype the most during the 24 days in
cell culture compared to the other tested culture conditions (Fig. 2).
Culture medium with FGF2 supported proliferation, but the expression
of FSHR decreased faster during the 24 days than in the FGF2-IGF2
combined medium. The regular medium without any additional growth
factors along with the medium only with IGF2 supported the expression
of FSHR, but the proliferation of cells was compromised.
3.3. FSH induces expression of GC marker genes FSHR, AMHR2, LHR,
CYP19A1, GnRHR, CYP11A1, but not AMH in CGCs under FGF2 and IGF2
supplemented growth medium and prolongs their expression in long-term cell
culture
We hypothesized that adding FSH to growth medium containing
IGF2 and FGF2 might help to retain the GC markers' expression and
Fig. 1. Gene expression of shown genes in CGCs and MGCs after freezing,
thawing and pooling. Expression levels are shown as mean ± SD. For CGCs
n = 9, except for AMH and CYP11A1 n = 6; for MGCs n = 6, except for AMH
and CYP11A1 n = 3. *, p < 0.05; Student's t-test after Bonferroni correction
for multiple testing. The “n” marks number of biological replicates.
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maintain the original GC morphology, because IGF2 has been shown to
be important factor together with FSH in regulating CYP19A1 expres-
sion and FGF2 supported proliferation of these cells.
To study the effect of FSH to CGCs, the cells were cultivated in
IGF2+FGF2 growth medium and FSH (1 U/ml) was added to half of the
cells starting from day 4 of culture. Time points were taken on days 0, 4,
7, 13 and 24 of the experiment. The CGCs cultivated in the growth
medium with FSH did not proliferate as fast as the cells cultivated
without FSH (Fig. 3a). By day 24, cell count of the CGCs that were
grown without FSH, had increased 3.32 times, and with FSH in the
medium, 1.82 times. The morphology of CGCs still changed from small
and round to long and narrow, however that change was much slower
in the medium where FSH was added (Fig. 3b).
The results of qPCR showed that adding FSH to the growth medium
helped to upregulate most of the GC markers that we studied (Fig. 4a,
supplementary table ST3). The expression levels of FSHR, AMHR2, LHR
and CYP19A1 followed a similar pattern – in the FSH medium they
stayed well above the starting level on days 7 and 13 but dropped to
barely detectable levels by day 24. Without adding FSH to the medium
the expression levels dropped below the original level much faster. The
expression of GnRHR followed a similar pattern, except by day 24,
when the expression levels were comparable to the original expression
level. The expression of CYP11A1 acted differently, dropping below
detection level on day 7 but rapidly increasing by day 13, with added
FSH, followed by a decrease by day 24. In the medium without FSH the
decrease was steadier but ended up at the same level. The expression of
AMH however, dropped right after the start of the experiment and
stayed very low until the end of cultivation in both growth media.
The differences between the two growth media were not as big
when comparing the expression levels of growth factors and their re-
ceptors (Fig. 4b). The expression levels of IGF1, FGF2 and FGFR1 in-
creased in both growth media by the end of the experiment while re-
maining lower in the FSH medium. The expression levels of IGF2,
IGF1R, IGF2R and INSR generally decreased but were higher in the FSH
medium. The expression of FGFR1 increased in both growth media but
more so in the medium without FSH. The expression of FGFR2 was
undetectable in the beginning of the experiment and increased above
the detection limit in both growth media by the end of the experiment.
The expression levels of FGFR3 and FGFR4 dropped in both media,
except FGFR3 expression that increased by day 24 in both growth
media.
3.4. FSH induces expression of GC marker genes FSHR, AMHR2, LHR,
CYP19A1, CYP11A1, but not AMH and GnRHR in MGCs under FGF2 and
IGF2 supplemented growth medium and prolongs their expression in long-
term cell culture
To study the effect of FSH to MGCs, the same protocol as used for
CGCs was utilized. Cells were cultivated in IGF2+FGF2 growth
medium and FSH (1 U/ml) was added to half of the cells starting from
day 4 of culture. Time points were taken on days 0, 4, 7, 13 and 24 of
the experiment.
The MGCs cultivated with or without FSH had similar proliferation
Fig. 2. FSHR expression level change relative to day 0 in different mediums (a).
Cumulative cell count of CGCs cultivated in different growth media on days 0,
4, 7, 13 and 24 (b). Expression levels and cell counts are shown as mean ± SD;
n = 3.
Fig. 3. Cumulative cell count of CGCs cultivated in different growth media on days 0, 4, 7, 13 and 24 (a). CGC morphology cultivated in different growth media on
days 1, 4, 7, 13 and 24 before passaging. The scale bar corresponds to 100 μm (b). Cell counts are shown as mean ± SD; n = 3.
K. Hensen, et al. Molecular and Cellular Endocrinology 510 (2020) 110816
4
speeds (Fig. 5a). The biggest difference was seen on day 7, where the
cell count in the medium without FSH was about 480 000 and in the
FSH medium about 312 000. On day 13 the cell counts were close to
500 000; and on day 24 the cell counts were around 2 million.
The morphology of MGCs changed again from small and round to
long and narrow (Fig. 5b). This change was slower in the FSH medium,
but the difference wasn't as big as for CGCs.
The results of qPCR showed that, in general, the expression of GC
markers in MGCs (Fig. 6, supplementary table ST4) changed quite si-
milarly to CGCs, however, they were mostly down-regulated faster
Fig. 4. Gene expression of shown genes in CGCs that were cultured in serum-free growth medium with IGF2 and FGF2. FSH (1 U/ml) was added to half of the cells
starting from day 4. Growth medium was exchanged daily and time points were taken on days 0, 4, 7, 13 and 24. qPCR results of GC markers (a) and other targets (b)
were analysed using ΔΔCt method, where SDHA was used as a reference gene and the results are shown in fold changes relative to day 0, except for FGFR2, in which
case the gene expression levels are normalized to SDHA. Results are expressed as mean ± SD; n = 3. * (blue asterisk), p < 0.05 gene expression in IGF2+FGF2
medium between day 0 and the corresponding time point; * (red asterisk), p < 0.05 gene expression in IGF2+FGF2+FSH medium between day 0 and the
corresponding time point; * (black asterisk), p < 0.05 gene expression in the corresponding time point between IGF2+FGF2 medium and IGF2+FGF2+FSH
medium; Student's t-test after Bonferroni correction for multiple testing. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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(Fig. 6a) and there were markers which expression was regulated dif-
ferentially on day 13 between CGCs and MGCs when FSH was added to
the medium (supplementary table ST5). The expression levels of FSHR,
AMHR2, LHR, CYP19A1 and CYP11A1 all increased in either FSH
medium or both media, but then decreased to barely detectable levels
by the end of the experiment. In contrast to CGCs, GnRHR expression
increased in both media by day 7 and then dropped back to the original
level by days 13 and 24. The expression of AMH dropped in both media
already by day 4 and stayed low until the end of the experiment, just
like in CGCs.
In general, the expression levels of our chosen growth factors and
their receptors followed similar patterns in MGCs and in CGCs, al-
though the average differences between the two media were smaller in
MGCs (Fig. 6b). The subtle differences we noted between the two
granulosa cell types were associated with the FSH response on day 13
(supplementary table ST5).
4. Discussion
Cultivation of primary human GCs has provided important knowl-
edge on follicular biology that is crucial for understanding impaired
folliculogenesis in female infertility. However, these studies have been
challenging for a long time, because the primary cells: 1) are limited in
availability; 2) proliferate very slowly in culture; and 3) tend to lose
their characteristic marker gene expression in cell culture. Additionally,
GCs are usually obtained during IVF procedure, meaning that they are
in the luteinized state and are unresponsive to gonadotropin stimula-
tions immediately after derivation (Ophir et al., 2014).
Most of the current GC culture protocols are not suitable for cul-
turing cells more than a week or they complement growth medium with
FBS, the composition (including various growth factors) of which can
vary and therefore cause unpredicted differences in the results of
multiple experiments. In the current study, we established a serum-free
protocol for in vitro cultivation of primary human GCs, by further
developing the protocols published by Ophir et al. (2014) and
Baumgarten et al. (2015), and making them more suitable for long-term
cell culture, so that the expression of GC marker genes is maintained for
at least two weeks.
Although our initial focus was on finding optimal culture conditions
for long-term culturing of primary granulosa cells, the serum-free cul-
ture protocol allowed us to monitor the response to FSH in CGCs and
MGCs for up to 20 days, highlighting distinctive response patterns in
these two granulosa cell types. With the exception for GnRHR and AMH
and by looking only the response trends, both cell types responded to
FSH with the eventual upregulation of common granulosa markers such
as FSHR, AMHR2, LHR, CYP19A1 and CYP11A1, however, there were
differences when and for how long the upregulated expression was
maintained. While the FSHR expression patterns were similar in both
cell types, the expression of AMHR2 and LHR proved to be statistically
different between CGCs and MGCs on day 13. The expression levels of
AMHR2 and LHR had already dropped below the starting level by day
13 in MGCs, even with FSH, suggesting that its effect on preserving
granulosa phenotype is shorter in MGCs. The expression of CYP19A1
seems to be supported longer in CGCs, while in case of CYP11A1 there
was a clear difference in the expression timing. The positive effect of
FSH on the expression of CYP11A1 was more rapid in MGCs (expression
peak on day 7) compared to CGCs (expression peak on day 13), but by
day 24 the expression dropped to similarly low levels in both cell types.
These results are in concordance with a previous study (Ophir et al.,
2014), where FSH was added to MGCs on day 4 and after 3 days they
also saw an increase in LHR, CYP19A1 and CYP11A1 expression levels.
Perhaps the most interesting difference between the two cell types
was noted in the GnRHR expression pattern. In MGCs GnRHR expres-
sion seems to be upregulated in both growth media by day 7, but in
CGCs the upregulation was more dependent on FSH and the expression
stayed high for longer period of time than in MGCs. However, by day 24
its expression was close to the starting levels in both media in both cell
types. As the function of GnRHR in granulosa cells is not well known, it
Fig. 5. Cumulative cell count of MGCs cultivated in different growth media on days 0, 4, 7, 13 and 24 (a). MGC morphology cultivated in different growth media on
days 1, 4, 7, 13 and 24 before passaging. The scale bar corresponds to 100 μm (b). Expression levels and cell counts are shown as mean ± SD; n = 3.
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is intriguing that our results point to potentially different roles in CGCs
and MGCs. One of the FSH-dependent mechanisms where the differ-
ential response may be important is the selection of dominant follicle
(Mihm and Evans, 2008), where cumulus cells could have a distinct role
in fine-tuning the responsiveness to GnRH via FSH-dependent upregu-
lation of GnRHR.
AMH expression decreased very rapidly in both media and both cell
types in our study. Previously, it has been shown that adding AMH to
the growth medium significantly reduces the upregulating effect of FSH
to the expression levels of CYP19A1 and FSHR (Pellatt et al., 2011).
There is an open discussion about the effect of FSH on the expression of
AMH and whether FSH might be inducing or reducing the expression of
AMH (Dewailly et al., 2016). Our experiments where AMH expression
decreased in the medium without FSH and did not increase after ad-
dition of FSH, support the findings where FSH does not induce the
expression of AMH. At the same time, it is interesting, that FSH seemed
to support the expression of AMHR2 in CGCs, but not much in MGCs
under our culture conditions. These findings could be valuable insights
for further studies of these effects and we think that our culture con-
ditions are good basis for this. In parallel, the time-dependent expres-
sion patterns of other markers allow us to speculate about the differ-
entiation status of the granulosa cells and the fact that we were not able
to see increased expression of AMH may also reflect cell differentiation
status and the limits of the current culture conditions. All in all, our
studies indicate that the effect of FSH on GC marker genes is on average
stronger in CGCs compared to MGCs, suggesting that CGCs are more
sensitive to FSH stimulation.
When looking at the expression patterns of the selected growth
factors and their receptors in CGCs and MGCs we also noted some in-
teresting differences. Although not statistically different, the expression
of IGF2 seemed to be increased in CGCs by FSH, but not in MGCs, also
suggesting that CGCs are more sensitive to FSH. Likewise, we see si-
milar trends on the expression levels of IGF1R, IGF2R and INSR. Out of
the three receptors, INSR seems to have most distinctive pattern in the
FSH-dependent expression regulation between the two granulosa cell
types. The CGCs responded more effectively to FSH with the upregu-
lation of INSR and showed significant difference on day 13. Even
though the differences in FSH response for the expression of IGF2 and
IGF2R were not statistically significant between CGCs and MGCs, there
is still a clear tendency supporting the hypothesis that in the growth
medium CGCs are more sensitive to FSH compared to the MGCs. As it is
known that oocyte is dependent on CGCs in the glucose metabolism
(Russell and Robker, 2007), the increased sensitivity of the INSR in
CGCs may be important for the final maturation of oocyte. Similarly,
the FSH-dependent trend of increased expression of IGF2 from CGCs has
been seen before and was proposed to be important during the final
steps of follicular maturation (Baumgarten et al., 2015). Moreover, the
oocyte can potentiate the expression of IGF2 from CGCs via secretion of
BMP15 and GDF9 (Hobeika et al., 2018). Interestingly, this effect seems
to be at least partially associated with the BMP15-dependent upregu-
lation of FSHR (Shimizu et al., 2019), which shows again the im-
portance of FSH-dependent regulatory mechanisms in follicular ma-
turation. We think that the complex interactions of different growth
factors in MGCs and CGCs should be further studied in parallel under
more defined culture conditions and the results from current study will
help to implement this strategy in future research.
The expression levels of GC markers correlated with cell mor-
phology. When markers' expression levels were high, cells were small
and round, similar to their original appearance. When markers' ex-
pression levels started decreasing, the cells stared to elongate, became
thinner and ended up looking more like fibroblasts. This also correlated
to the expression levels of FGF2 and its main receptor FGFR1 – the
higher the expression, the more similar the cells looked to fibroblasts.
Interestingly, the expression of FGFR1 was also more dependent on FSH
in CGCs compared to MGCs. Here the addition of FSH tended to de-
crease the expression level of FGFR1 and preserved longer the granulosa
cell phenotype.
Since in vivo the expression levels of FSHR, LHR, CYP19A1 and
CYP11A1 reach their peak in the preovulatory non-luteinized state and
are lower after oocyte retrieval (Ophir et al., 2014), we can hypothesize
that the cells become more similar to preovulatory GCs in cell culture,
using the long-term culture protocol developed in the current study.
Thus, the GCs cultured according to our serum-free protocol could be
used as a model for studying earlier stages of folliculogenesis with non-
luteinized GCs.
5. Conclusion
In conclusion, our new cell culture protocol allows cultivating pri-
mary human GCs while maintaining the expression of GC markers for at
least two weeks of culture. Additionally, using serum-free conditions in
GC culture reduces the variability between different experiments, and
provides a reliable tool for future research to study the biology of
human GCs.
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Fig. 6. Gene expression of shown genes in MGCs that were cultured in serum-free growth medium with IGF2 and FGF2. FSH (1 U/ml) was added to half of the cells on
starting from day 4. Growth medium was exchanged daily and time points were taken on days 0, 4, 7, 13 and 24. qPCR results of GC markers (a) and other targets (b)
were analysed using ΔΔCt method, where SDHA was used as a reference gene and the results are shown in fold changes relative to day 0, except for FGFR2 and
FGFR3, in which case the gene expression levels are normalized to SDHA. Results are expressed as mean ± SD; n = 3. *(blue asterisk), p < 0.05 gene expression in
IGF2+FGF2 medium between day 0 and the corresponding time point; *(red asterisk), p < 0.05 gene expression in IGF2+FGF2+FSH medium between day 0 and
the corresponding time point; *(black asterisk), p < 0.05 gene expression in the corresponding time point between IGF2+FGF2 medium and IGF2+FGF2+FSH
medium; Student's t-test after Bonferroni correction for multiple testing. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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References
Baumgarten, S.C., Convissar, S.M., Zamah, A.M., Fierro, M.A., Winston, N.J., Scoccia, B.,
Stocco, C., 2015. FSH regulates IGF-2 expression in human granulosa cells in an AKT-
dependent manner. J. Clin. Endocrinol. Metab. 100 (8), E1046–E1055. https://doi.
org/10.1210/jc.2015-1504.
Bayasula, Iwase, A., Kiyono, T., Takikawa, S., Goto, M., Nakamura, T., Nagatomo, Y.,
Nakahara, T., Kotani, T., Kobayashi, H., Kondo, M., Manabe, S., Kikkawa, F., 2012.
Establishment of a human nonluteinized granulosa cell line that transitions from the
gonadotropin-independent to the gonadotropin-dependent status. Endocrinology 153
(6), 2851–2860. https://doi.org/10.1210/en.2011-1810.
Ben-Haroush, A., Abir, R., Ao, A., Jin, S., Kessler-Icekson, G., Feldberg, D., Fisch, B., 2005.
Expression of basic fibroblast growth factor and its receptors in human ovarian fol-
licles from adults and fetuses. Fertil. Steril. 84 (Suppl. 2), 1257–1268. https://doi.
org/10.1016/j.fertnstert.2005.05.018.
Brůcková, L., Soukup, T., Moos, J., Moosová, M., Pavelková, J., Rezábek, K., Vísek, B.,
Mokrý, J., 2008. The cultivation of human granulosa cells. Acta Medica (Hradec
Kralove) 51 (3), 165–172. https://doi.org/10.14712/18059694.2017.19.
Chang, H.-M., Fang, L., Cheng, J.-C., Taylor, E.L., Sun, Y.-P., Leung, P.C.K., 2016. Effects
of growth differentiation factor 8 on steroidogenesis in human granulosa-lutein cells.
Fertil. Steril. 105 (2), 520–528. https://doi.org/10.1016/j.fertnstert.2015.10.034.
Chatterjee, R., Helal, M., Mobberley, M., Ryder, T., Bajoria, R., 2014. Impaired ster-
oidogenesis and apoptosis of granulosa-luteal cells in primary culture induced by cis-
platinum. Am. J. Obstet. Gynecol. 210 (3), 252.e1–252.e7. https://doi.org/10.1016/
j.ajog.2013.11.014.
Cheon, K.Y., Chung, Y.J., Cho, H.H., Kim, M.R., Cha, J.H., Kang, C.S., Lee, J.Y., Kim, J.H.,
2018. Expression of müllerian-inhibiting substance/anti-müllerian hormone type II
receptor in the human theca cells. J. Clin. Endocrinol. Metab. 103 (9), 3376–3385.
https://doi.org/10.1210/jc.2018-00549.
Choi, J.H., Gilks, C.B., Auersperg, N., Leung, P.C.K., 2006. Immunolocalization of gona-
dotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during
follicular development in the human ovary. J. Clin. Endocrinol. Metab. 91 (11),
4562–4570. https://doi.org/10.1210/jc.2006-1147.
Dewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., Catteau-Jonard, S., 2016.
Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during
folliculogenesis in the human normal and polycystic ovary. Hum. Reprod. Update 22
(6), 709–724. https://doi.org/10.1093/humupd/dmw027.
Di Blasio, A.M., Vigano, P., Cremonesi, L., Carniti, C., Ferrari, M., Ferrari, A., 1993.
Expression of the genes encoding basic fibroblast growth factor and its receptor in
human granulosa cells. Mol. Cell. Endocrinol. 96 (1–2), R7–11. https://doi.org/10.
1016/0303-7207(93)90111-v.
Di Blasio, A.M., Viganó, P., Ferrari, A., 1994. Insulin-like growth factor-II stimulates
human granulosa-luteal cell proliferation in vitro. Fertil. Steril. 61 (3), 483–487.
https://doi.org/10.1016/s0015-0282(16)56580-7.
Edson, M.A., Nagaraja, A.K., Matzuk, M.M., 2009. The mammalian ovary from genesis to
revelation. Endocr. Rev. 30 (6), 624–712. https://doi.org/10.1210/er.2009-0012.
el-Roeiy, A., Chen, X., Roberts, V.J., LeRoith, D., Roberts, C.T., Yen, S.S., 1993. Expression
of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin
receptor genes and localization of the gene products in the human ovary. J. Clin.
Endocrinol. Metab. 77 (5), 1411–1418. https://doi.org/10.1210/jcem.77.5.8077342.
Figenschau, Y., Sundsfjord, J.A., Yousef, M.I., Fuskevåg, O.M., Sveinbjörnsson, B.,
Bertheussen, K., 1997. A simplified serum-free method for preparation and cultiva-
tion of human granulosa-luteal cells. Hum. Reprod. 12 (3), 523–531. https://doi.org/
10.1093/humrep/12.3.523.
Geisthovel, F., Moretti-rojas, I., Asch, R.H., Rojas, F.J., 1989. Expression of insulin-like
growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in
human preovulatory granulosa cells. Hum. Reprod. 4 (8), 899–902. https://doi.org/
10.1093/oxfordjournals.humrep.a137007.
Giudice, L.C., 1992. Insulin-like growth factors and ovarian follicular development.
Endocr. Rev. 13 (4), 641–669. https://doi.org/10.1210/edrv-13-4-641.
Gospodarowicz, D., Bialecki, H., 1979. Fibroblast and epidermal growth factors are mi-
togenic agents for cultured granulosa cells of rodent, porcine, and human origin.
Endocrinology 104 (3), 757–764. https://doi.org/10.1210/endo-104-3-757.
Grossman, M.P., Nakajima, S.T., Fallat, M.E., Siow, Y., 2008. Müllerian-inhibiting sub-
stance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell
culture. Fertil. Steril. 89 (5 Suppl), 1364–1370. https://doi.org/10.1016/j.fertnstert.
2007.03.066.
Havelock, J.C., Rainey, W.E., Carr, B.R., 2004. Ovarian granulosa cell lines. Mol. Cell.
Endocrinol. 228 (1–2), 67–78. https://doi.org/10.1016/j.mce.2004.04.018.
Hillier, S.G., 1994. Current concepts of the roles of follicle stimulating hormone and lu-
teinizing hormone in folliculogenesis. Hum. Reprod. 9 (2), 188–191. https://doi.org/
10.1093/oxfordjournals.humrep.a138480.
Hobeika, E., Armouti, M., Fierro, M., Winston, N., Scoccia, H., Zamah, A.M., Stocco, C.,
2018. Oocyte secreted factors regulate insulin growth factor 2 (IGF2) expression in
human primary cumulus granulosa cells. Fertil. Steril. 105 (1). https://doi.org/10.
1016/j.fertnstert.2018.07.301.
Hosokawa, K., Aharoni, D., Dantes, A., Shaulian, E., Schere-levy, C., Atzmon, R., Kotsuji,
F., Oren, M., Vlodavsky, I., Amsterdam, A., 1998. Modulation of Mdm2 expression
and p53-induced apoptosis in immortalized human ovarian granulosa cells.
Endocrinology 139 (11), 4688–4700. https://doi.org/10.1210/endo.139.11.6280.
Ishiwata, I., Ishiwata, C., Soma, M., Kobayashi, N., Ishikawa, H., 1984. Establishment and
characterization of an estrogen-producing human ovarian granulosa tumor cell line.
J. Natl. Cancer Inst. 72 (4), 789–800.
Karamouti, M., Kollia, P., Kallitsaris, A., Vamvakopoulos, N., Kollios, G., Messinis, I.E.,
2008. Growth hormone, insulin-like growth factor I, and leptin interaction in human
cultured lutein granulosa cells steroidogenesis. Fertil. Steril. 90 (4 Suppl),
1444–1450. https://doi.org/10.1016/j.fertnstert.2007.08.076.
Kõks, S., Velthut, A., Sarapik, A., Altmäe, S., Reinmaa, E., Schalkwyk, L.C., Fernandes, C.,
Lad, H.V., Soomets, U., Jaakma, U., Salumets, A., 2009. The differential tran-
scriptome and ontology profiles of floating and cumulus granulosa cells in stimulated
human antral follicles. Mol. Hum. Reprod. 16 (4), 229–240. https://doi.org/10.
1093/molehr/gap103.
Kossowska-Tomaszczuk, K., Pelczar, P., Güven, S., Kowalski, J., Volpi, E., De Geyter, C.,
Scherberich, A., 2010. A novel three-dimensional culture system allows prolonged
culture of functional human granulosa cells and mimics the ovarian environment.
Tissue Eng. 16 (6), 2063–2073. https://doi.org/10.1089/ten.TEA.2009.0684.
Kranc, W., Brązert, M., Ożegowska, K., Nawrocki, M.J., Budna, J., Celichowski, P.,
Dyszkiewicz-Konwińska, M., Jankowski, M., Jeseta, M., Pawelczyk, L., Bruska, M.,
Nowicki, M., Zabel, M., Kempisty, B., 2017. Expression profile of genes regulating
steroid biosynthesis and metabolism in human ovarian granulosa cells—a primary
culture approach. Int. J. Mol. Sci. 18 (12). https://doi.org/10.3390/ijms18122673.
Lasley, B.L., Wang, C.F., Yen, S.S., 1975. The effects of estrogen and progesterone on the
functional capacity of the gonadotrophs. J. Clin. Endocrinol. Metab. 41 (5), 820–826.
https://doi.org/10.1210/jcem-41-5-820.
McAllister, J.M., 1995. Functional, long-term human theca and granulosa cell cultures
from polycystic ovaries. Endocrine 3 (2), 143–149. https://doi.org/10.1007/
BF02990066.
Mihm, M., Evans, A.C.O., 2008. Mechanisms for dominant follicle selection in mono-
vulatory species: a comparison of morphological, endocrine and intraovarian events
in cows, mares and women. Reprod. Domest. Anim. 43 (Suppl. 2), 48–56. https://doi.
org/10.1111/j.1439-0531.2008.01142.x.
Nishi, Y., Yanase, T., Mu, Y.M., Oba, K., Ichino, I., Saito, M., Nomura, M., Mukasa, C.,
Okabe, T., Goto, K., Takayanagi, R., Kashimura, Y., Haji, M., Nawata, H., 2001.
Establishment and characterization of a steroidogenic human granulosa-like tumor
cell line, KGN, that expresses functional follicle-stimulating hormone receptor.
Endocrinology 142 (1), 437–445. https://doi.org/10.1210/endo.142.1.7862.
Nitta, M., Katabuchi, H., Ohtake, H., Tashiro, H., Yamaizumi, M., Okamura, H., 2001.
Characterization and tumorigenicity of human ovarian surface epithelial cells im-
mortalized by SV40 large T antigen. Gynecol. Oncol. 81 (1), 10–17. https://doi.org/
10.1006/gyno.2000.6084.
Oktay, K., Briggs, D., Gosden, R.G., 1997. Ontogeny of follicle-stimulating hormone re-
ceptor gene expression in isolated human ovarian follicles. J. Clin. Endocrinol.
Metab. 82 (11), 3748–3751. https://doi.org/10.1210/jc.82.11.3748.
Ophir, L., Yung, Y., Maman, E., Rubinstein, N., Yerushalmi, G.M., Haas, J., Barzilay, E.,
Hourvitz, A., 2014. Establishment and validation of a model for non-luteinized
human mural granulosa cell culture. Mol. Cell. Endocrinol. 384 (1–2), 165–174.
https://doi.org/10.1016/j.mce.2014.01.018.
Pellatt, L., Rice, S., Dilaver, N., Heshri, A., Galea, R., Brincat, M., Brown, K., Simpson,
E.R., Mason, H.D., 2011. Anti-Müllerian hormone reduces follicle sensitivity to fol-
licle-stimulating hormone in human granulosa cells. Fertil. Steril. 96 (5), 1246–1251.
https://doi.org/10.1016/j.fertnstert.2011.08.015.
Prapa, E., Vasilaki, A., Dafopoulos, K., Katsiani, E., Georgoulias, P., Messini, C.I.,
Anifandis, G., Messinis, I.E., 2015. Effect of Anti-Müllerian hormone (AMH) and bone
morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human
luteinizing granulosa cells through Smad5 signalling. J. Assist. Reprod. Genet. 32 (7),
1079–1088. https://doi.org/10.1007/s10815-015-0494-2.
Price, C.A., 2016. Mechanisms of fibroblast growth factor signaling in the ovarian follicle.
J. Endocrinol. 228 (2), R31–R43. https://doi.org/10.1530/JOE-15-0414.
Quennell, J.H., Stanton, J.A., Hurst, P.R., 2004. Basic fibroblast growth factor expression
in isolated small human ovarian follicles. Mol. Hum. Reprod. 10 (9), 623–628.
https://doi.org/10.1093/molehr/gah083.
Rainey, W.H., Sawetawan, C., Shay, J.W., Michael, M.D., Mathis, J.M., Kutteh, W., Byrd,
W., Carr, B.R., 1994. Transformation of human granulosa cells with the E6 and E7
regions of human papillomavirus. J. Clin. Endocrinol. Metab. 78 (3), 705–710.
https://doi.org/10.1210/jcem.78.3.8126145.
Rechler, M.M., Nissley, S.P., 1986. Insulin-like growth factor (IGF)/somatomedin receptor
subtypes: structure, function, and relationships to insulin receptors and IGF carrier
proteins. Horm. Res. 24 (2–3), 152–159. https://doi.org/10.1159/000180554.
Russell, D.L., Robker, R.L., 2007. Molecular mechanisms of ovulation: Co-ordination
through the cumulus complex. Hum. Reprod. Update 13 (3), 289–312. https://doi.
org/10.1093/humupd/dml062.
Ryan, K.J., Petro, Z., 1966. Steroid biosynthesis by human ovarian granulosa and thecal
cells. J. Clin. Endocrinol. Metab. 26 (1), 46–52. https://doi.org/10.1210/jcem-26-
1-46.
Sasano, H., Okamoto, M., Mason, J.I., Simpson, E.R., Mendelson, C.R., Sasano, N.,
Silverberg, S.G., 1989. Immunolocalization of aromatase, 17 alpha-hydroxylase and
side-chain-cleavage cytochromes P-450 in the human ovary. J. Reprod. Fertil. 85 (1),
163–169. https://doi.org/10.1530/jrf.0.0850163.
Sasano, H., Sasano, N., 1989. What’s new in the localization of sex steroids in the human
ovary and its tumors? Pathol. Res. Pract. 185 (6), 942–948. https://doi.org/10.1016/
S0344-0338(89)80302-4.
Schipper, I., Fauser, B.C., van Gaver, E.B., Zarutskie, P.W., Dahl, K.D., 1993. Development
of a human granulosa cell culture model with follicle stimulating hormone respon-
siveness. Hum. Reprod. 8 (9), 1380–1386. https://doi.org/10.1093/oxfordjournals.
humrep.a138265.
K. Hensen, et al. Molecular and Cellular Endocrinology 510 (2020) 110816
9
Shimizu, K., Nakamura, T., Bayasula, Nakanishi, N., Kasahara, Y., Nagai, T., Murase, T.,
Osuka, S., Goto, M., Iwase, A., Kikkawa, F., 2019. Molecular mechanism of FSHR
expression induced by BMP15 in human granulosa cells. J. Assist. Reprod. Genet. 36
(6), 1185–1194. https://doi.org/10.1007/s10815-019-01469-y.
Taieb, J., Grynberg, M., Pierre, A., Arouche, N., Massart, P., Belville, C., Hesters, L.,
Frydman, R., Catteau-Jonard, S., Fanchin, R., Picard, J.-Y., Josso, N., Rey, R.A., di
Clemente, N., 2011. FSH and its second messenger cAMP stimulate the transcription
of human anti-müllerian hormone in cultured granulosa cells. Mol. Endocrinol. 25
(4), 645–655. https://doi.org/10.1210/me.2010-0297.
Tajima, K., Hosokawa, K., Yoshida, Y., Dantes, a, Sasson, R., Kotsuji, F., Amsterdam, a,
2002. Establishment of FSH-responsive cell lines by transfection of pre-ovulatory
human granulosa cells with mutated p53 (p53val135) and Ha-ras genes. Mol. Hum.
Reprod. 8 (1), 48–57. https://doi.org/10.1093/molehr/8.1.48.
Tureck, R.W., Strauss, J.F., 1982. Progesterone synthesis by luteinized human granulosa
cells in culture: the role of de novo sterol synthesis and lipoprotein-carried sterol. J.
Clin. Endocrinol. Metab. 54 (2), 367–373. https://doi.org/10.1210/jcem-54-2-367.
van den Berg Bakker, C.A.M., Hagemeijer, A., Franken Postma, E.M., Smit, V.T.H.B.M.,
Kuppen, P.J.K., Claasen, H.H.V.R., Cornelisse, C.J., Schrier, P.I., 1993. Establishment
and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell
line: growth features and cytogenetics. Int. J. Canc. 53 (4), 613–620. https://doi.org/
10.1002/ijc.2910530415.
Watson, R., Anthony, F., Pickett, M., Lambden, P., Masson, G.M., Thomas, E.J., 1992.
Reverse transcription with nested polymerase chain reaction shows expression of
basic fibroblast growth factor transcripts in human granulosa and cumulus cells from
in vitro fertilisation patients. Biochem. Biophys. Res. Commun. 187 (3), 1227–1231.
https://doi.org/10.1016/0006-291x(92)90434-m.
Weenen, C., Laven, J.S.E., von Bergh, A.R.M., Cranfield, M., Groome, N.P., Visser, J.A.,
Kramer, P., Fauser, B.C.J.M., Themmen, A.P.N., 2004. Anti-Müllerian hormone ex-
pression pattern in the human ovary: potential implications for initial and cyclic
follicle recruitment. Mol. Hum. Reprod. 10 (2), 77–83. https://doi.org/10.1093/
molehr/gah015.
Wickham, E.P., Tao, T., Nestler, J.E., McGee, E.A., 2013. Activation of the LH receptor up
regulates the type 2 adiponectin receptor in human granulosa cells. J. Assist. Reprod.
Genet. 30 (7), 963–968. https://doi.org/10.1007/s10815-013-0012-3.
Willis, D.S., Mason, H.D., Watson, H., Franks, S., 1998. Developmentally regulated re-
sponses of human granulosa cells to insulin-like growth factors (IGFs): IGF-I and IGF-
II action mediated via the type-I IGF receptor. J. Clin. Endocrinol. Metab. 83 (4),
1256–1259. https://doi.org/10.1210/jcem.83.4.4699.
Xu, J., Xu, F., Letaw, J.H., Park, B.S., Searles, R.P., Ferguson, B.M., 2016. Anti-Müllerian
hormone is produced heterogeneously in primate preantral follicles and is a potential
biomarker for follicle growth and oocyte maturation in vitro. J. Assist. Reprod. Genet.
33 (12), 1665–1675. https://doi.org/10.1007/s10815-016-0804-3.
Yamoto, M., Shima, K., Nakano, R., 1992. Gonadotropin receptors in human ovarian
follicles and corpora lutea throughout the menstrual cycle. Horm. Res. Paediatr. 37
(Suppl 1), 5–11. https://doi.org/10.1159/000182335.
Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., Madden, T.L., 2012. Primer-
BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC
Bioinf. 13:134. https://doi.org/10.1186/1471-2105-13-134.
Yung, Y., Aviel-Ronen, S., Maman, E., Rubinstein, N., Avivi, C., Orvieto, R., Hourvitz, A.,
2014. Localization of luteinizing hormone receptor protein in the human ovary. Mol.
Hum. Reprod. 20 (9), 844–849. https://doi.org/10.1093/molehr/gau041.
K. Hensen, et al. Molecular and Cellular Endocrinology 510 (2020) 110816
10
